| For: |
Quan MF, Xiao LH, Liu ZH, Guo H, Ren KQ, Liu F, Cao JG, Deng XY. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i43/7680.htm |
| Number | Citing Articles |
| 1 |
. 2017; doi: 10.70675/f95cdb23zecb6z4543z9164ze58fd37f2268
|
| 2 |
Yicheng Chen, Qiaoli Huang, Hua Zhou, Yueping Wang, Xian Hu, Tao Li. Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells. Oncotarget 2016; 7(31) doi: 10.18632/oncotarget.10409
|
| 3 |
Lei Tan, Xiaohua Duan, Pratyusha Mutyala, Ting Zhou, Sadaf Amin, Tuo Zhang, Brian Herbst, Gokce Askan, Tomer Itkin, Zhaoying Xiang, Fabrizio Michelassi, Michael D Lieberman, Christine A Iacobuzio-Donahue, Steven D Leach, Todd Evans, Shuibing Chen, Hua Lu. A targetable pathway to eliminate TRA-1-60+/TRA-1-81+ chemoresistant cancer cells. Journal of Molecular Cell Biology 2023; 15(6) doi: 10.1093/jmcb/mjad039
|
| 4 |
Jianyun Zhu, Shijia Wang, Yue Chen, Xiaoting Li, Ye Jiang, Xue Yang, Yuan Li, Xiaoqian Wang, Yu Meng, Mingming Zhu, Xiao Ma, Cong Huang, Rui Wu, Chunfeng Xie, Shanshan Geng, Jieshu Wu, Caiyun Zhong, Hongyu Han. miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells. The Journal of Nutritional Biochemistry 2017; 44 doi: 10.1016/j.jnutbio.2017.02.020
|
| 5 |
Xiaocheng Cao, Lihua Liu, Xiaozheng Cao, Yinghong Cui, Chang Zou, A. Chen, Yebei Qiu, Meifang Quan, Kaiqun Ren, Xiangding Chen, Jianguo Cao. The DNMT1/miR-34a/FOXM1 Axis Contributes to Stemness of Liver Cancer Cells. Journal of Oncology 2020; 2020 doi: 10.1155/2020/8978930
|
| 6 |
Kushal Kandhari, Hina Agraval, Arpana Sharma, Umesh C. S. Yadav, Rana P. Singh. Functional Food and Human Health. 2018; doi: 10.1007/978-981-13-1123-9_26
|
| 7 |
Jinggang Mo, Yingpeng Tong, Junxia Ma, Kunpeng Wang, Yifu Feng, Liezhi Wang, Hao Jiang, Chong Jin, Junmin Li. The mechanism of flavonoids from Cyclocarya paliurus on inhibiting liver cancer based on in vitro experiments and network pharmacology. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1049953
|
| 8 |
Zecheng Hu, Xiaocheng Cao, Yu Fang, Guoxing Liu, Chengzhi Xie, Ke Qian, Xiaohua Lei, Zhenyu Cao, Huihui Du, Xiangding Cheng, Xundi Xu. Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer. Biomedicine & Pharmacotherapy 2018; 105 doi: 10.1016/j.biopha.2018.06.029
|
| 9 |
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, Jesus Simal-Gandara, Dalia M. Kopustinskiene, Jurga Bernatoniene, Saeed Samarghandian. Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01906-y
|
| 10 |
Chunlin Xu, Weiwei Sun, Jinglei Liu, Haihong Pu, Yinghong Li. MiR-342-3p inhibits LCSC oncogenicity and cell stemness through HDAC7/PTEN axis. Inflammation Research 2022; 71(1) doi: 10.1007/s00011-021-01521-7
|
| 11 |
Valery Vilchez, Lilia Turcios, Francesc Marti, Roberto Gedaly. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. World Journal of Gastroenterology 2016; 22(2): 823-832 doi: 10.3748/wjg.v22.i2.823
|
| 12 |
Sha He, Yi Lu, Xia Liu, Xin Huang, Evan T. Keller, Chao-Nan Qian, Jian Zhang. Wnt3a: functions and implications in cancer. Chinese Journal of Cancer 2015; 34(3) doi: 10.1186/s40880-015-0052-4
|
| 13 |
Na Li, Ying Zhu. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma. Therapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284818821560
|
| 14 |
Lu Liu, Jürgen Borlak. Advances in Liver Cancer Stem Cell Isolation and their Characterization. Stem Cell Reviews and Reports 2021; 17(4) doi: 10.1007/s12015-020-10114-6
|
| 15 |
Ronghua Wang, Qian Sun, Peng Wang, Man Liu, Si Xiong, Jing Luo, Hai Huang, Qiang Du, David A. Geller, Bin Cheng. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells. Oncotarget 2016; 7(5) doi: 10.18632/oncotarget.6805
|
| 16 |
Qi Wen, Chang Xu, Jie Zhou, Nuo-Min Liu, Ying-Hong Cui, Mei-Fang Quan, Jian-Guo Cao, Kai-qun Ren. RETRACTED ARTICLE: 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5419-5
|
| 17 |
Nahida Siddiqui, Lubna Abidin, Nazima Nisar, Irfan Ahmad, Ali Nasir Siddiqui. Polyphenols-based Nanotherapeutics for Cancer Management. 2021; doi: 10.1007/978-981-16-4935-6_7
|
| 18 |
Heng Xiao, Ning Jiang, Baoyong Zhou, Qiang Liu, Chengyou Du. TAZ regulates cell proliferation and epithelial–mesenchymal transition of human hepatocellular carcinoma. Cancer Science 2015; 106(2) doi: 10.1111/cas.12587
|
| 19 |
JI QIN GAI, XIA SHENG, JIAN MIN QIN, KANG SUN, WEI ZHAO, LEI NI. The effect and mechanism of bufalin on regulating hepatocellular carcinoma cell invasion and metastasis via Wnt/β-catenin signaling pathway. International Journal of Oncology 2016; 48(1) doi: 10.3892/ijo.2015.3250
|
| 20 |
Zhao-Shan Niu, Wen-Hong Wang, Xian-Ning Dong, Li-Mei-Li Tian. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(29): 4240-4260 doi: 10.3748/wjg.v26.i29.4240
|
| 21 |
Monica A. Kamal, Yasmine M. Mandour, Mostafa K. Abd El-Aziz, Ulrike Stein, Hend M. El Tayebi. Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges. Molecules 2022; 27(17) doi: 10.3390/molecules27175537
|
| 22 |
Eshvendar Reddy Kasala, Lakshmi Narendra Bodduluru, Rajaram Mohanrao Madana, Athira K. V, Ranadeep Gogoi, Chandana C Barua. Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives. Toxicology Letters 2015; 233(2) doi: 10.1016/j.toxlet.2015.01.008
|
| 23 |
Doris Schneller, Peter Angel. Hepatocellular Carcinoma. 2019; doi: 10.15586/hepatocellularcarcinoma.2019.ch1
|
| 24 |
Rainbow Wing Hei Leung, Terence Kin Wah Lee. Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers 2022; 14(21) doi: 10.3390/cancers14215468
|
| 25 |
Retracted article: Natural product-based therapeutics for the treatment of cancer stem cells: a patent review (2010 - 2013). Expert Opinion on Therapeutic Patents 2015; 25(6) doi: 10.1517/13543776.2015.1042242
|
| 26 |
Kai-yue Tang, Shi-lin Du, Qian-lei Wang, Yi-fan Zhang, Hai-yan Song. Traditional Chinese medicine targeting cancer stem cells as an alternative treatment for hepatocellular carcinoma. Journal of Integrative Medicine 2020; 18(3) doi: 10.1016/j.joim.2020.02.002
|
| 27 |
Wanmi Sui, Weijia Wang. Bufalin Suppresses Colorectal Cancer Cells by the Blockade of Canonical Wnt Signaling Pathway. 2022 4th International Conference on Intelligent Medicine and Image Processing 2022; doi: 10.1145/3524086.3524088
|
| 28 |
YINGHONG CUI, SHUWEN SUN, KAIQUN REN, MEIFANG QUAN, ZHENWEI SONG, HUI ZOU, DUO LI, JIANGUO CAO. Reversal of liver cancer-associated stellate cell-induced stem-like characteristics in SMMC-7721 cells by 8-bromo-7-methoxychrysin via inhibiting STAT3 activation. Oncology Reports 2016; 35(5) doi: 10.3892/or.2016.4637
|
| 29 |
Ketao Zhang, Siyao Che, Chuzhi Pan, Zheng Su, Shangyou Zheng, Shanglin Yang, Huayao Zhang, Wenda Li, Weidong Wang, Jianping Liu. The SHH/Gli axis regulates CD90‐mediated liver cancer stem cell function by activating the IL6/JAK2 pathway. Journal of Cellular and Molecular Medicine 2018; 22(7) doi: 10.1111/jcmm.13651
|
| 30 |
Gleyne Lopes Kujew Biagini, Carmem Austrália Paredes Marcondes Ribas, Henrique Diez Higashi, Vanessa Yumi Hirata, Maria Augusta Karas Zella, Ivan Bartolomei, Giuliana Biagini, Luiz Martins Collaço. Wnt3a but not CDX-2 expression is associated with differentiated thyroid cancer. Revista da Associação Médica Brasileira 2022; 68(3) doi: 10.1590/1806-9282.20211132
|